Literature DB >> 17827144

Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery.

María José de Jesús Valle1, Nora Salamanca Uranga, Francisco Gónzalez López, Alfonso Domínguez-Gil Hurlé, Amparo Sánchez Navarro.   

Abstract

OBJECTIVES: To characterize the distribution of linezolid in lung when it accesses this organ from the systemic circulation and when administered through the pulmonary route and to evaluate the influence of the 'respiratory mode' in the pulmonary distribution for both routes.
METHODS: The study was conducted with 24 Wistar rats divided into four groups treated with linezolid under different experimental conditions. After the animals had been subjected to a tracheotomy followed by mechanical ventilation, the lungs were isolated. After a 5 min stabilization period, the antibiotic was administered through the systemic or the pulmonary route and samples of efferent fluid (EF) were collected using a previously programmed fraction collector. Samples of bronchoalveolar fluid (BALF) and of lung tissue were also taken at the end of each experiment. The concentrations of linezolid in the samples were determined using an HPLC technique with UV detection.
RESULTS: The administration of linezolid through the inhalatory route significantly increased the levels of the drug in lung tissue and BALF with lung tissue/EF partition coefficients of 8.33 +/- 2.51 as compared with 1.90 +/- 0.78 for systemic administration. Also, the decrease in respiratory rate together with the increase in tidal volume favoured the process of linezolid distribution in pulmonary tissues and fluids.
CONCLUSIONS: Administration through the pulmonary route affords and excellent method for passively vectoring linezolid to the pulmonary fluids and tissues and the respiratory mode seems to affect the disposition of the antibiotic in this tissue for both administration routes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827144     DOI: 10.1093/jac/dkm306

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.

Authors:  Olga B Garbuzenko; Maha Saad; Vitaly P Pozharov; Kenneth R Reuhl; Gediminas Mainelis; Tamara Minko
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.

Authors:  G Mainelis; S Seshadri; O B Garbuzenko; T Han; Z Wang; T Minko
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-03-26       Impact factor: 2.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.